Advertisement

Topics

Yissum Research and Development Company Company Profile

11:45 EST 14th December 2018 | BioPortfolio


News Articles [1036 Associated News Articles listed on BioPortfolio]

Hemostemix Announces Development of an ACP-01 Allogeneic Process and Initiation of R&D for Autologous NCP-01

Hemostemix (TSXV:HEM; OTCQB:HMTXF) is pleased to provide the following update on its research and development activities. As quoted in the press release: Further to the Company’s press release date...

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 07092018] Prices from USD $250

SummaryYissum Research Development Company of the Hebrew University of Jerusalem Ltd YRDC, a subsidiary of Hebrew University of Jerusalem, is a technology transfer company. The company offers marketin...

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryYissum Research Development Company of the Hebrew University of Jerusalem Ltd YRDC, a subsidiary of Hebrew University of Jerusalem, is a technology transfer company. The company offers marketin...

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 20062018] Prices from USD $250

SummaryYissum Research Development Company of the Hebrew University of Jerusalem Ltd YRDC is a technology transfer company that offers marketing the inventions and knowhow generated by the University'...

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 18072018] Prices from USD $250

SummaryYissum Research Development Company of the Hebrew University of Jerusalem Ltd YRDC is a technology transfer company that offers marketing the inventions and knowhow generated by the University'...

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 12062018] Prices from USD $250

SummaryYissum Research Development Company of the Hebrew University of Jerusalem Ltd YRDC is a technology transfer company that offers marketing the inventions and knowhow generated by the University'...

#Cannabisstocks: Cronos Group Inc. (NASDAQ: $CRON) (TSX: $CRON.TO) Partners with Technion Research & Development Foundation for #Cannabinoid-Based Skin Care Treatments

TORONTO - October 15, 2018 (Investorideas.com Newswire) Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), announced today that it has entered into a sponsored research ag...

Agile research to complement agile development: a proposal for an mHealth research lifecycle

Agile research to complement agile development: a proposal for an mHealth research lifecycleAgile research to complement agile development: a proposal for an mHealth research lifecycle, Published onli...

PubMed Articles [2642 Associated PubMed Articles listed on BioPortfolio]

Characteristics of Occupational Injuries in a Pharmaceutical Company in Iran.

To prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).

The relationship between exclusive breastfeeding and infant development: A 6- and 12-month follow-up study.

Breastfeeding offers several advantages for infants with research suggesting that it benefits development, including cognitive and language development. However, limited research has examined the bene...

A Man (or a Woman) is Known by the Company He/She Keeps.

Bad Company: Microenvironmentally Mediated Resistance to Targeted Therapy in Melanoma.

This review will focus on the role of the tumor microenvironment (TME) in the development of drug resistance in melanoma. Resistance to mitogen-activated protein kinase inhibitors (MAPKi) in melanoma ...

Identifying priorities for HIV-associated tuberculosis research through the WHO guidelines process.

Guidelines developed by the WHO aim to provide recommendations to support best practice in health delivery, with a focus on low-income and middle-income countries. As part of the guideline development...

Clinical Trials [3683 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Development of Clinical and Biological Database

The BCB is a tool: - for research in analytical and public health epidemiology, biological research and for the development of data useful for clinical research and therapeutic tr...

Brain Development Research Program

Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of...

Study Evaluating Intervention in the Development of Clinical Research in Non-Academic Health Institution (ERNU)

This study evaluates the interventions of the Cancéropôle Nord-Ouest in the development of clinical research in non-academic health institution. The randomization, in open label,determin...

Companies [5649 Associated Companies listed on BioPortfolio]

Yissum Ltd.

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. was founded in 1964 to protect and commercialize the Hebrew University’s intellectual property....

Yissum Research Development Company of the Hebrew University of Jerusalem

Yissum, the Technology Transfer Company (TTC) is responsible for recognizing and managing the intellectual property assets of the Hebrew University in Jerusalem.A researcher presenting an innovative b...

Yissum Research and Development Company

Yissum Research Development Company Ltd.

Yissum Research Development Company Ltd. and BioLineRx Ltd.

More Information about "Yissum Research and Development Company" on BioPortfolio

We have published hundreds of Yissum Research and Development Company news stories on BioPortfolio along with dozens of Yissum Research and Development Company Clinical Trials and PubMed Articles about Yissum Research and Development Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Yissum Research and Development Company Companies in our database. You can also find out about relevant Yissum Research and Development Company Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record